XAGE Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

--

Open

--

VWAP

--

Vol

--

Mkt Cap

--

Low

--

Amount

--

EV/EBITDA(TTM)

--

Total Shares

--

EV

1.31M

EV/OCF(TTM)

--

P/S(TTM)

1.45

Longevity Health Holdings, Inc. is focused on longevity and healthy aging, encompassing the latest scientific advances in regenerative bio-aesthetics. The Company has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity.

Show More

Events Timeline

(ET)

2025-07-14

16:40:10

Longevity Health, True Health to combine in all-stock transaction

2025-05-27 (ET)

2025-05-27

09:22:10

Longevity Health extends cash runway into 1Q26

2025-05-21 (ET)

2025-05-21

16:39:24

Longevity announces continued Nasdaq listing to complete 20/20 BioLabs deal

2025-05-15 (ET)

2025-05-15

08:12:46

Longevity Health reports unaudited Q1 revenue $663,000, up 8% year-over-year

2025-05-12 (ET)

2025-05-12

08:20:11

Longevity Health announces 1-for-30 reverse stock split

2025-04-14 (ET)

2025-04-14

08:08:49

Longevity Health executes merger agreement with 20/20 Biolabs

News

Benzinga

Coinbase CEO Armstrong Invests in NewLimit, Secures $45 Million Funding

PRnewswire

2025-07-21PRnewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, ZIMV, XAGE on Behalf of Shareholders

PRnewswire

2025-07-18PRnewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ONCO, WAT, XAGE on Behalf of Shareholders

Globenewswire

2025-07-17Globenewswire

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Longevity Health Holdings, Inc. (NASDAQ: XAGE)

Benzinga

2025-07-15Benzinga

Why Longevity Health Stock Is Skyrocketing Today

TipRanks

2025-07-15TipRanks

Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!

Valuation Metrics

The current forward P/E ratio for Longevity Health Holdings Inc (XAGE.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Longevity Health Holdings Inc 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

AI Analysis

Annual

Quarterly

Whales Holding XAGE

Trading Trends

People Also Watch

Frequently Asked Questions

What is Longevity Health Holdings Inc (XAGE) stock price today?

The current price of XAGE is 0 USD — it has increased 0 % in the last trading day.

What is Longevity Health Holdings Inc (XAGE)'s business?

Longevity Health Holdings, Inc. is focused on longevity and healthy aging, encompassing the latest scientific advances in regenerative bio-aesthetics. The Company has two cosmetic product lines, Carmell Secretomeand and Elevai Exosomes, that support skin and hair health. All of its cosmetic skincare and haircare products are tailored to meet the demanding technical requirements of professional care providers and discerning retail consumers. The Carmell Secretome consists of a potent cocktail of growth factors, proteins, and peptides extracted from allogeneic human platelets. The Carmell Secretome product portfolio and pipeline includes Face and Neck Collection (Retail), ProSynergy Collection (Doctors/Medspas), and others. The Elevai Exosomes are nano-sized extracellular vesicles containing growth factors, cytokines, peptides, and other small molecules involved in the body’s natural healing process. The Elevai Exosomes skincare products include Elevai Empower and Elevai Enfinity.

What is the price predicton of XAGE Stock?

Wall Street analysts forecast XAGE stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for XAGE is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Longevity Health Holdings Inc (XAGE)'s revenue for the last quarter?

Longevity Health Holdings Inc revenue for the last quarter amounts to 503.61K USD, increased 3987.76 % YoY.

What is Longevity Health Holdings Inc (XAGE)'s earnings per share (EPS) for the last quarter?

Longevity Health Holdings Inc. EPS for the last quarter amounts to -1.56 USD, decreased -67.36 % YoY.

How many employees does Longevity Health Holdings Inc (XAGE). have?

Longevity Health Holdings Inc (XAGE) has 15 emplpoyees as of February 09 2026.

What is Longevity Health Holdings Inc (XAGE) market cap?

Today XAGE has the market capitalization of 0.00 USD.